ICMR Transfers 41 Public Health Technologies to Industry at India’s Largest Biomedical Innovation Event

The Indian Council of Medical Research (ICMR) has organized the India’s largest largest biomedical innovation and technology transfer event in the national capital. The Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect and this event marked as a major step to transforming the indigenous medical research in to the real world healthcare products.

ICMR Launches Major Biomedical Innovation Platform in India

The event was held at the Manekshaw Centre in New Delhi and established one of the India’s first structured platforms which is focused entirely on biomedical innovation showcasing and technology transfer.

The initiative has been launched under the ICMR’s Medical Innovation Patent Mitra programme and designed to bridge the gap between laboratory research and market-ready healthcare solutions.

The idea is simple as many important innovations remain inside the research institutions due to lack of commercialization support.

This platform aims to solve that challenge.

41 Public Health Technologies Transferred to Industry Partners

The biggest highlight of the event was the transfer of 41 public health technologies from the ICMR institutes and innovators to industry players.

These technologies will now move towards the further development, large-scale manufacturing and commercial rollout.

The transferred innovations covers the multiple critical healthcare sectors, including the,

• Advanced diagnostic technologies
• Vaccines
• Medical devices
• Biomedical public health solutions

Key technologies included the,

• Typhoid and Paratyphoid vaccines
• Disease diagnostics

This move is expected to speed up the healthcare access across Indian and reducing dependence on imported technologies.

First-Ever Transfer of KFD and Chandipura Virus Biomaterials

The major milestone of the event was India’s first-ever transfer of well characterized inactivated biomaterials related to the,

• Kyasanur Forest Disease (KFD) virus
• Chandipura virus

This is a important development for the India’s vaccine research and biomedical manufacturing ecosystem.

Such biomaterials are crucial for the advanced research, vaccine development and public health preparedness.

By enabling the industry access, India is also strengthening domestic capability in infectious disease innovation.

Why Medical Innovations Patent Mitra Matters

Healthcare innovation often faces the common bottleneck.

As the research gets completed, patents are filed but the products fail to reach hospitals or patients due to weak commercialization pathways.

Medical Innovations Patent Mitra aims to change this challenge.

The program focuses on to the,

• Protecting the biomedical intellectual property
• Supporting technology transfer
• Connecting innovators with the private industry
• Accelerating product development timelines
• Encouraging startup participation

This creates the practical innovation pipeline from idea to patient care.

More Than 100 Medical Technologies Showcased

Apart from the technology transfers, the event has also witnessed over 100 healthcare innovations.

These included the products and research across the,

• Diagnostics
• Therapeutics
• Medical devices
• Public health technologies
• Startup-led health innovation

The platform allowed the direct interaction between the,

• Researchers
• Startups
• Manufacturers
• Investors
• Healthcare industry leaders

Reports Released at the Event

Two major documents were also launched at the evnet.

Indian Biomedical Patent Landscape Report

This report maps the India’s biomedical patent ecosystem and identifies innovation trends.

Technology Compendium

This provides the consolidated overview of the healthcare technologies ready for transfer and development.